(Q37349800)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Giuseppe Costante

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Zélia Francis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Martin Schlumberger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sebastiano Filetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Endocrinology and Metabolism

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

35-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

False serum calcitonin high levels using a non-competitive two-site IRMA.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET1023

A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET1023

Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET1023

Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET1023

Continuing controversies in the management of thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET1023

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET1023

American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules

21 January 2018

1 reference

12 December 2020

"Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature

1 reference

12 December 2020

Thyroid origin of Calcitonin

1 reference

12 December 2020

Increased calcitonin level in thyroid nodules without medullary carcinoma

1 reference

12 December 2020

Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma

1 reference

12 December 2020

Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature.

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors

1 reference

12 December 2020

Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders

1 reference

12 December 2020

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

12 December 2020

A case of metastatic medullary thyroid carcinoma: early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens

1 reference

12 December 2020

Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma

1 reference

12 December 2020

Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter

1 reference

12 December 2020

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma

1 reference

12 December 2020

Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination?

1 reference

12 December 2020

Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels

1 reference

12 December 2020

The calcitonin conundrum--is it time for routine measurement of serum calcitonin in patients with thyroid nodules?

1 reference

12 December 2020

Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease

1 reference

12 December 2020

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging

1 reference

12 December 2020

Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland

1 reference

12 December 2020

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

12 December 2020

Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases

1 reference

12 December 2020

Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.

1 reference

12 December 2020

Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience.

1 reference

12 December 2020

Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients

1 reference

12 December 2020

Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma

1 reference

12 December 2020

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

1 reference

12 December 2020

Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.

1 reference

12 December 2020

Genetic testing for cancer predisposition

1 reference

12 December 2020

Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level

1 reference

12 December 2020

Early Diagnosis of Medullary Carcinoma of the Thyroid Gland by Means of Calcitonin Assay

1 reference

12 December 2020

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

1 reference

12 December 2020

Routine measurement of plasma calcitonin in nodular thyroid diseases

1 reference

12 December 2020

Reference intervals for serum calcitonin in men, women, and children

1 reference

12 December 2020

Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.

1 reference

12 December 2020

Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules

1 reference

12 December 2020

Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group

1 reference

12 December 2020

Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests

1 reference

12 December 2020

Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking

1 reference

12 December 2020

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine

1 reference

12 December 2020

New therapeutic approaches to treat medullary thyroid carcinoma

1 reference

12 December 2020

Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules

1 reference

12 December 2020

Medullary thyroid carcinoma

1 reference

12 December 2020

Editorial: Calcitonin determination in patients with nodular thyroid disease

1 reference

12 December 2020

Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma

1 reference

12 December 2020

Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma

1 reference

12 December 2020

Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).

1 reference

12 December 2020

Calcitonin kinetics in the early postoperative period of medullary thyroid carcinoma

1 reference

12 December 2020

A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA.

1 reference

12 December 2020

Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma

1 reference

12 December 2020

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

1 reference

12 December 2020

Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times

1 reference

12 December 2020

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCPENDMET1023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079272%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference